UNSPSC 51162032: Guaifenesin/oxtriphylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162032 Guaifenesin/oxtriphylline (Commodity) shows a significant disconnect between its nominal scope and recent state and local procurement activity. The code designation suggests a single active pharmaceutical ingredient combination, yet the recent opportunities posted under this code involve naloxone procurement, on-site pharmacy services, direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical supply agreements—none of which center on guaifenesin/oxtriphylline formulations. State and local governments are sourcing through this code primarily for emergency medical supplies (naloxone kits), managed pharmacy services for county employee health plans, and cooperative purchasing vehicles for broad pharmaceutical and OTC product portfolios. Issuing bodies include county health departments and community health initiatives (Seminole County, Florida), county government employee health programs (Hall County, Georgia), state health agencies conducting market research (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances managing statewide and regional pharmaceutical distribution (Minnesota Department of Administration via MMCAP). The code shows little relevant recent activity aligned with its literal product name; the mismatch suggests either deliberate cross-coding for administrative purposes or a labeling error in source systems.

Recent activity spans Florida, Georgia, Texas, and Minnesota. Representative opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; Hall County, Georgia's RFQ/P #47-010 (posted May 4, 2026; due June 4, 2026) for on-site pharmacy services at the Hall County Government Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible county employees and retirees; the Texas Health and Human Services Commission's RFI No. HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit manager arrangements; and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) establishing contracts for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026, and a two-year initial term.